BioHarvest Sciences Inc. Common Stock (BHST) Earnings Analysis

BioHarvest Sciences Inc. Common Stock (BHST) next reports earnings on 2026-08-10, consensus EPS -0.13 USD. Last quarter (2026-05-14) it beat with EPS -0.11 USD vs -0.13 USD est (+15.4%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E -3.52.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BHST next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.13 USD
Revenue estimate0.01B

BHST earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.11 USD-0.13 USD+15.4%Beat
2026-03-31-0.1 USD-0.105 USD+4.8%Beat
2025-11-13-0.14 USD-0.14 USD0%Beat
2025-08-11-0.15 USD-0.11 USD-36.4%Miss
2025-05-15-0.13 USD-0.15 USD+13.3%Beat
2025-03-31-0.17 USD-0.12 USD-41.7%Miss
2024-11-25-0.16 USD-0.05 USD-220%Miss
2024-10-23-0.04202 USD-0.1 USD+58%Beat

Beat rate: 5/8 (63%) over reported quarters with consensus data.

BHST valuation and analyst view

Trailing P/E-3.52
Trailing EPS-0.5046 USD
Price / book2.15
Dividend yield0.00%
Market cap0.04B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)
Avg price target10 USD

Related research pages

Frequently asked questions

When is BioHarvest Sciences Inc. Common Stock (BHST)'s next earnings date?

BioHarvest Sciences Inc. Common Stock is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.13 USD and revenue estimate of 0.01B.

Did BHST beat earnings last quarter?

In its 2026-05-14 report, BHST posted EPS of -0.11 USD versus a -0.13 USD estimate — a beat of 15.4%.

What is BHST's earnings track record?

Over the last 8 reported quarters with consensus data, BHST beat estimates 5 times (63%).

What is BHST's current P/E ratio and EPS?

BHST trades at a trailing P/E of -3.52 on trailing EPS of -0.5046021008617455 USD.

What do analysts rate BHST?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 10 USD.